Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
130
L. J. D. Sebastian et al.
13.2.3 Pathology andClinical Aspects
Cerebral AVMs are vascular lesions composed of abnormal tangles of blood vessels with pathologic shunting from arte­rial to venous side without an intervening normal capillary bed (Fig.13.1).
The nidal vessels are indeterminate and indistinguishable from arteries or veins. Macroscopically, they range from well-differentiated arteries and veins to highly malformed, hyalinized, poorly differentiated vessels with thick and thin walls. Microscopically, most of these nidal vessels have only a single endothelial layer like capillaries but unlike capillar­ies are hugely dilated.
The most common modes of clinical presentation of intra­cranial AVMs are, in the order, spontaneous intracranial hemorrhage, seizures, and headaches not associated with hemorrhage. Focal neurological decits and other symptoms like tinnitus and trigeminal neuralgia are some of the less common presenting symptoms. Most of these clinical symp­toms can be correlated with specic angio-architectural fea­tures of the underlying AVM.
13.2.4 Classication
Valvanis and Yasargil developed a classication based on the location of the nidus [6]. They classied brain AVMs into two main groups, i.e., convexity AVMs with supra and infratentorial subgroups and in deep central AVMs with supra and infratentorial subgroups. These supercial AVMs are sub-classied into sulcal, gyral, and mixed sulco-gyral types based on their relation with adjacent sul-
AVM
Superficial
Sulcal
Gyral
Deep
Sub-arachanold
Parenchymal
cus, gyrus, and subcortical white matter. Deep brain AVMs are also further subclassied into subarachnoid AVMs, parenchymal AVMs, plexal or intraventricular AVMs, and mixed deep AVMs. Classication of AVM is detailed in Table13.1.
Lasjaunias included the role of feeding pedicles and draining veins in addition to the location in the classica­tion of AVM.Supercial AVMs like sulcal and gyral AVMs were supplied by pial arteries in the subpial spaces and drained into supercial cortical veins, whereas deeper AVMs were supplied by the perforator/choroidal arteries and drained into the deep venous system. Most of the indi­vidual lesions, however, involve more than one compart­ment. For example, rare cortical lesions were supplied exclusively by cortical arteries and drained into supercial cortical veins.
13.2.5 Angioarchitecture ofAVM
Structurally, an AVM consists of four main components: the nidus, feeding arteries, draining veins, and the adjacent or intervening brain parenchyma. DSA is the gold standard tool to analyze the rst three components.
Nidus is derived from a Latin word meaning nest. Other synonyms used could be the epicenter, nucleus, or focus of the AVM.The nidus represents the area of the entire AVM angioarchitecture between readily identiable distal seg­ments of feeding arteries and draining veins [1]. It is the source of all hemodynamic changes observed up and down­stream of the AVM and is composed of multiple coiled and intercommunicating vascular channels that empty into thin­walled tortuous veins. Angiographically, the nidus may con­sist of a plexiform network of vascular channels, large arteriovenous stulae, or a mix of both plexiform and stu­lous parts (Fig.13.2).
The nidus of a cerebral AVM, especially that of a larger one, can be composed of many compartments. A compart­ment is dened as an intranidal vascular unit characterized by its own feeding arteries, AV shunting, and a draining vein. The compartments of AVM are not rigid, well-dened vascu­lar units but are rather hemodynamic units that may intercommunicate.
Intranidal vascular cavities are weak components of an AVM architecture and are represented by arterial aneurysms, arterial pseudoaneursyms (post bleed), intranidal aneurysms, venous pseudoaneurysm (post bleed), and venous intranidal ectasias. These cavities are prone to rupture and hence should be targeted during embolization.
Sulco-gyral
Fig. 13.1 Classication of AVM
Plexal/Ventricular
Feeding Arteries We have to determine the feeding artery
relationship to the nidus and look for any high-ow angio­pathic changes. Depending on the anatomical location of
13 Interventions inIntracranial andSpinal Arteriovenous Malformations
Table 13.1 Classication of AVM
Cortical/Pial arteries Perforators Choroidal arteries Deep venous system Supercial venous sys
Cortical Sulcal
Cortico­subcortical
Cortico-ventricular Sulco-gyral + + +
Deep seated +(insular and
Choroid plexus
Cortico-callosal +
AV M Gyral +
+
cerebellar)
+
+
+ + +
+ + +
+
131
+
+
+
+
+
a
Fig. 13.2 Microcatheter runs show various combination in the nidus (a) Cork-screw type (b) Mixed cork-screw and linear vessels (c) linear frail vessesls
b
c
Arterial high ow angiopathic changes include arterial enlargements/ectasias, arterial stenosis, aneurysms, and watershed transfer. High-ow stulas show arterial ow aneurysms, which are directly seen on the arteries supplying the nidus or distant from the nidus. High-pressure ow can induce endothelial/smooth muscle hypertrophy resulting in arterial stenosis. The watershed transfer is induced by the perinidal brain parenchyma, which receives sub-optimal blood ow.
Fig. 13.3 Cerebral AVMs
arteries in relation to the brain parenchyma, they are divided into pial, dural, perforating arteries; choroidal arteries; and retrograde collaterals. Hemodynamically, they are also clas­sied into dominant and supplementary, while geometrically they are divided into direct/terminal feeders, pseudotermi­nal, and indirect/transit/en passage feeders based on their supply to AVM and brain parenchyma (Fig.13.3, 13.4, 13.5,
13.6 and 13.7) [6].
Draining Veins
One should attempt to identify and classify
all the draining veins of an AVM.Those with only one or two draining veins have a higher propensity to bleed. Hemodynamically, they are classied into main and acces­sory veins. Anatomically, the draining veins are classied into those connecting to the supercial cortical venous sys­tem or deep venous system. In general, supercial AVMs (sulcal or cortical) drain into cortical veins, while deep brain AVMs drain into sub-ependymal veins. Angiographic evi­dence of unexpected venous drainage should represent a sec­ondary event. For example, any sulcal AVM draining into the deep venous system indicates that the supercial cortical vein(s) draining it have likely thrombosed.
132
L. J. D. Sebastian et al.
Venous reux can be into the cortical veins or deep venous system (Fig. 13.8). Deep venous reux is associated with higher bleeding risk. While cortical venous reux itself is not associated with increased bleeding risk, it can interfere with normal parenchymal drainage and can be a cause of symptoms.
Venous high-ow angiopathy changes include venous ste­nosis, venous ectasias, and venous pouches or varices. Venous stenosis without pouches is a high risk factor for bleeding.
Hemorrhagic Risk One of the primary goals of analysis of angioarchitecture of an AVM is assessing the risk of rupture. Table13.2 summarizes the angiographic features indicating a high risk for rupture (bleed) of an AVM.
13.2.6 Imaging inCerebral AVMs
Cerebral AVMs being complex conditions, every imaging modality cross-sectional imaging (CT and MRI) as well as DSA are exploited to the maximum to extract information that is useful for management in a given patient. Yet, DSA remains the gold standard for analyzing angioarchitectural features described earlier.
Fig. 13.4 Right ICA run showing right choroidal AVM with direct feeder from pericallosal artery (straight arrow) and indirect feeder from Anterior choroidal artery (double ended arrow)
Fig. 13.5 (a) Right ICA run shows splenial AVM with feeder from pericallosal artery. (b) Right vertebral run showing retrograde pial-pial collaterals between distal branches of PCA and splenial artery
a
CT Scan
• Non-contrast CT is usually the rst imaging to detect
intracranial bleeding in patients presenting acutely. It can
b
13 Interventions inIntracranial andSpinal Arteriovenous Malformations
Fig. 13.6 Pre-nidal and intranidal aneurysms in left posterior temporal AVM in left vertebral run
Fig. 13.7 Law parietal AVM case with major supply from left MCA; Right ICA AP and lateral runs showing watershed transfer with peri-nidal angiogenesis between left ACA-MCA teritorry (straight arrow)
133
a
Fig. 13.8 (a) Left vertebral run showing cerebellar AVM; (b) Capillary phase showing venous reux into posterior fossa veins; (c) Venous phase shows parenchymal congestion in posterior fossa
b
c
134
L. J. D. Sebastian et al.
Table 13.2 The angiographic features indicating a high risk for rup­ture (bleed) of an AVM
1. Nidus a. Size: < 2cm b. Location: Deep > supercial c. Nidal type: Fistulous > plexiform d. Nidal aneurysms
2. Arterial side a. Arterial aneurysms
3. Venous side a. Single draining vein b. Enlarged draining veins c. Venous stenosis (without pouches) d. Deep venous reux e. Venous pseudoaneurysms
also show calcications in the nidus, venous sacs, or in parenchyma.
• More importantly, NCCT is done as a baseline before embolization. Immediately after the embolization CT scan is repeated, which should be carefully studied for any bleed (perinidal, subarachnoid, or intraventricular) to ag any procedure-related complications.
• Additionally, post-procedure CT demonstrates the dispo­sition of embolic material also. Some centers use CT angiography to study the location and architecture of an AVM.
MRI
• MRI is invaluable to precisely localize brain AVM and therefore aid in its classication.
• It depicts parenchymal changes secondary to the AVM like hemorrhage, gliosis, mass effect, and hydrocephalus.
• It also shows hemosiderin deposition, reminiscent of pre­vious bleed, in the parenchyma and within the nidus as well.
• Advanced imaging tools like DTI and functional MRI can also be used in treatment planning and follow-up.
• MRI is a good adjuvant (to DSA) tool for short- and long­term follow-up of patients with brain AVMs.
• Arterial spin labeling (ASL) detects arterial transit arti­facts in the veins (due to fast-owing blood), which is mainly useful post-treatment to look for any residual/ recurrent AVM [7, 8].
Table 13.3 Spetzler martin classication
AVM characteristics Points
Size of AVM
<3cm 1 3–6cm 2 >6cm 3
Location of AVM
Non-eloquent 0 Eloquent 1
Venous drainage of AVM
Supercial 0 Deep 1
• The architectural analysis is complete with the super­selective microcatheter angiography, which is described in a later section.
13.2.7 Grading ofCerebral AVMs
Spetzler Martin classication system is the most commonly used grading system (Table13.3). It is mainly designed to pre­dict the surgical outcomes [9]. The total score (ranging from 1 to 5) helps guide the decision-making process regarding the treatment approach, balancing the risks of surgery against the potential benets. Higher scores indicate a higher risk of neu­rological decits from surgery, inuencing the consideration of alternative treatments or careful weighing of intervention risks. Surgery is favored in low grades like grades I, II, and III.
Over the years various other grading systems, such as the
Supplementary Grading System, Lawton’s Modication of AVM Grading System, and the Buffalo Grading System, have been developed to assess arteriovenous malformations (AVMs) [10, 11]. These systems offer nuanced criteria for pre- dicting treatment outcomes, surgical risks, and technical com­plexities associated with endovascular interventions. Buffalo grading system is an endovascular grading scale taking into account the number, diameter, and eloquent location of those arterial pedicles. Each system serves to guide clinicians in treatment planning and decision-making for AVM patients though extensive clinical validations are lacking for them.
13.2.8 Treatment ofBrain AVMs
DSA
• DSA is the gold standard for the analysis of the angioar­chitectural features of an AVM and therefore planning its treatment strategies.
• Additional imaging techniques provided by most of the modern angiographic suites like cone beam CT angiogra­phy and 3D rotational angiography help understand the AVM architecture better.
13.2.8.1 Indications andGoals
All ruptured intracranial AVMs require treatment to prevent recurrent hemorrhage and attendant morbidity and mortality. However, the selection of unruptured AVMs for treatment is not that straightforward. The ARUBA trial showed a three­fold increase in morbidity and mortality in the multimodality interventional arm compared to the medical arm [12]. The SIVM study also corroborated these ndings [13].
13 Interventions inIntracranial andSpinal Arteriovenous Malformations
135
The target of any kind of treatment of cerebral AVMs is the
nidus, or more precisely, the complete elimination of the same. However, this may not be feasible in all types of AVM architecture. Hence, the aggressiveness of treatment pursued in a given patient has to be tempered by a sense of clinical pragmatism, which takes into consideration the specic angio-architectural features in the individual, the severity of his/her clinical symptoms, modality-based expertise available in the treating center (microsurgery, endovascular emboliza­tion, radiosurgical obliteration), and the risks involved in the treatment itself. Accordingly, the therapeutic goal in a given individual may be curative or partial treatment directed to high-risk areas or palliation aimed at alleviating symptoms rather than a cure. Conservative or only symptomatic medical treatment is also an appropriate option in some patients.
13.2.8.2 Endovascular Treatment
(Embolization) ofBrain AVMs
The following sections begin with the dening current role of endovascular treatment (EVT) in the management of brain AVMs followed by a brief on the advances in the devices and
a
b
technology and then by a detailed description of embolic agents. The last sections dwell on the technical aspects of embolization with liquid embolic agents. The terms EVT and embolization are used interchangeably in the text.
Role ofEVT
(i) Curative: It is possible to cure certain brain AVMs by
EVT alone (Fig.13.9). Many endovascular series report AVMs with the following characteristics as suitable for curative embolization: small/medium-sized, compact nidus, supercial location, and accessible feeders [14].
Larger AVMs are generally not suitable for curative embolization, though, with the advent of newer tech­niques, the proportion and size of curable AVMs increasing.
(ii) Partial-targeted embolization: It means the elimination of
weaker architectural areas (e.g., aneurysms, stulas) alone by embolization, especially in large ruptured AVMs, which are otherwise difcult to cure by embolization alone.
(iii) Partial embolization—presurgical/ preradiosurgical: In
large AVMs, embolization is used to reduce the AVM
c
d
Fig. 13.9 (a & b) Left ICA angiogram shows compact nidus lling from distal MCA branches; Sonic microcatheter was navigated and 20% glue was injected; (c) Control angiogram shows complete emboli-
e
f
zation of the nidus; (d) Post embo CT showing embolic material; (e, f) Post embolisation angiogram and CT conrming the technical success of the procedure
136
L. J. D. Sebastian et al.
a d
e
f
cb
g
Fig. 13.10 (a, b) MRI shows gliosis and bleed in left occipital lobe; (c, d, e) Right vertebral artery run shows nidus with venous pseudoaneu-
rysm; 20% glue was injected into the pseudoaneurysm; (f & g) Control
size so that they can be treated later by surgery or radio­surgery/as an adjunct (Fig.13.10).
(iv) Palliative: In large and/or untreatable AVMs, EVT can
help to treat weak areas (e.g., nidal or feeding artery aneurysms) or to alleviate symptoms by reducing ow (e.g., neuralgia due to nerve compression by vessels).
Advances inEndovascular Devices andEmbolic Agents
• Biplane angio-suite is the essential component of a neuro­interventional department. All the modern angio-suites provide 3D rotational angiography and cone beam CT angiography, which are very useful in analyzing the AVM architecture and planning embolization.
• Flow-guided microcatheters come in 1.2F and 1.5F and have made superselective navigation easier. Distal access cathe­ters also help in this cause, particularly in tortuous anatomy.
• Detachable tip microcatheters meant a quantum jump in developing curative embolization techniques.
angiogram shows residual nidus with obliteration of the venous sac. The residual nidus was sent to gamma knife therapy
• Liquid embolic agents are the mainstay of AVM treat­ment. Especially, the nonadhesive copolymer liquid embolic agents have changed the paradigm of AVM treatment.
Embolic Agents
Historically, particulate embolic agents, such as PVA parti­cles, have been used in the endovascular treatment of brain AVMs in the early years. Currently, they have been almost completely replaced by liquid embolic agents (LEA). Coils are sometimes used alone or as an adjuvant to LEA in the embolization of high-ow stulous components and in some special techniques such as the pressure cooker technique.
LEAs fall into two major groups:
1. Cyanoacrylates, or adhesive liquid embolics, also known
commonly as “glue.”
2. Copolymers, or non-adhesive liquid embolics; DMSO as
a solvent is common to all of them.
13 Interventions inIntracranial andSpinal Arteriovenous Malformations
137
Each of the above groups have distinct properties such that the embolization techniques employing them also differ from each other. Hence, a review of commonly available LEAs and their properties is pertinent.
Cyanoacrylates (Glue)
• Various available cyanoacrylates are isobutyl
2- cyanoacrylate, n-butyl cyanoacrylate (nBCA), n-hexyl
cyanoacrylate (nHCA), and 2-octyl cyanoacrylate (OCA).
• Normally, cyanoacrylates contain monomeric molecules
while in liquid form. When exposed to blood or any ionic
solution, these molecules undergo a rapid exothermic
chain growth polymerization, resulting in an adhesive
material that occludes the blood vessel.
• Glue is mixed with iodized oil (Lipiodol, Guerbet,
Villepinte, France) before injection via a microcatheter
for two reasons: (i) to reduce the speed of polymerization
of glue which in pure form would instantly polymerize
and occlude the microcatheter; (ii) to give radioopacity to
glue which is otherwise radioluscent and not visible under
uoroscopy.
• The ratio between the cyanoacrylate and iodized oil deter-
mines the concentration of the glue prepared. For exam-
ple, 20% glue preparation contains cyanoacrylate and
iodized oil in the ratio of 1:4. The concentration required
in a given case depends on several factors, such as the
position of the microcatheter, the diameter of the emboli-
zed vessel, and the velocity of blood ow. For example, a
high ow stula requires high concentration (>90%) glue.
• Micronized tantalum powder is mixed in highly concen-
trated glue preparations to add radio-opacity. It is also
useful to reduce the viscosity of the oil.
• To prevent polymerization within the microcatheter, the
latter is initially ushed with 5–10% dextrose solution.
The volume of dextrose solution injected is often 2–3
times that of the dead space of the microcatheter. When
the microcatheter is in a wedged position in the feeder
artery, the dextrose accumulating in the feeder distal to
the tip acts like an extension of the microcatheter till the
stulous point. This is especially helpful when a micro-
catheter cannot be negotiated close to the stula/nidus via
a thin feeder.
• Due to its rapid polymerization on contact with blood,
glue can be injected only for a short duration of time—
usually less than a minute—before the feeder vascular
pedicle gets occluded.
• Glue is adhesive to the microcatheter (hence the name
adhesive embolics). Hence, prolonged injection and/or
reux along the catheter tip can lead to entrapment of the
microcatheter. Forcible pulling of the microcatheter then
can cause the rupture of blood vessels with dire conse-
quences. Hence, entrapped microcatheters are often left in situ by cutting them at groin (puncture site).
• Histoacryl, Glubran 2, Magic Glue, TruFill, and Fuaile are the commercially available cyanoacrylates manufac­tured by different companies. Of these, Histoacryl is the most widely used one and available in India. Magic glue contains nHCA and has the least adhesive strength to the microcatheter and hence allows prolonged glue injection.
Copolymers
The currently available copolymers are onyx, PHIL, and squid. Onyx is an EVOH copolymer with DMSO and micronized tantalum. EVOH is the active substance that solidies after DMSO dissipation. Micronized tantalum gives radiopacity of the embolic agent. The onyx vial has to be vigorously shaken just prior to its use to ensure homoge­neous mixing of the tantalum particles. Onyx is available as onyx 18, onyx 20, and onyx 34. The numbers indicate the viscosity in centipoise.
Squid It has the same components as onyx—EVOH copo-
lymer, micronized tantalum powder, and DMSO.The main difference between squid and onyx is the smaller grain size in squid to enhance the radiopacity and improve visibility during longer injection times. Squid is available in six differ­ent formulations: Squid 12, 12LD, 18, 18 LD, 34, 34LD (numbers indicate viscosity in centipoise).
PHIL It consists of two copolymers (polylactide-co-
glycolide and polyhydroxyethylmethacrylate) as active com­pounds and triiodophenol (an iodine compound); the latter for radiopacity. PHIL also uses DMSO as a solvent. A PHIL package consists of two pre-lled syringes containing 1ml of PHIL and another of DMSO.It is ready to use and doesn’t have to be shaken. PHIL is available in four formulations: PHIL LV, PHIL 25%, PHIL 30%, and PHIL 35%.
Unlike cyanoacrylates that are relatively hard in their
solid form, copolymers are more in a plastic state. All the copolymers occlude vessels by precipitation like that of hardening of lava ow in a volcano (from outside to inside). The solidication results from the dissipation of DMSO.The microcatheter is ushed with DMSO prior to the injection of the co-polymer. DMSO can cause local toxic effects on the embolized blood vessels, resulting in vasospasm, inamma­tion of the vessel wall, and angionecrosis. DMSO also dam­ages the synthetic material of the device, hence should be used with DMSO-compatible microcatheters only. The mechanism of precipitation takes a few minutes; hence, lon­ger injections are advocated with a detachable tip microcath­eter (most frequently used detachable tip microcatheters are
138
L. J. D. Sebastian et al.
apollo and Sonic). While reux is undesirable when using glue, reux is a part of the embolization in copolymers.
Embolization Techniques
Specic endovascular strategies and techniques depend on the choice of embolic agent(s). However, some general con­siderations are relevant here:
1. Access: A 6F femoral access is sufcient in most of the situ­ations, However, multiple vascular accesses like bifemoral along with radial may be needed when multiple simultane­ous LEA injection is planned as in multiplug (described later) technique. Femoral or neck venous access may also be needed when venous side embolization is contemplated.
2. Guiding: A 6F guide catheter placed in the neck vessel is generally adequate. Sometimes, coaxial system may be needed in tortuous neck anatomy. A distal access catheter can also be helpful in microcatheter navigation in difcult anatomy.
3. Angioarchitecture analysis: A detailed study of the angio­architecture using multiple superselective (microcatheter) angiography is an invaluable essential step before pro­ceeding with embolization (Fig.13.11). Such an analysis should be directed toward clarifying the following points.
a. Number, size, and nature of arterial pedicles—whether
direct/indirect or terminal/enpassant. This is espe­cially needed to choose a safe feeder for LEA injection.
b. Nature of the nidus: whether plexiform or stulous
or mixed? Whether it is multicompartmental and if so feeder(s) and draining vein(s) of each compartment.
c. The presence and extent of inter-communication
between the compartments.
d. Identifying all the draining veins, any venopathic
changes and assessing the suitability for venous side embolization.
e. Identifying weak or vulnerable areas in the arterial,
nidal, and venous sides and the feeder pedicle supply­ing the same.
4. For conducting the angioarchitecture study described above, a microcatheter can be sequentially navigated into all the possible feeders. Alternatively, multiple micro­catheters can be navigated at the same time into multiple pedicles. Bifemoral and radial accesses may be needed for this purpose. Simultaneous angiograms via two or more microcatheters can reveal even more functional and anatomic information.
Fig. 13.11 (a) Right ICA smart-mask showing splenial AVM with major feeders from pericallosal artery and callosomarginal artery (b) Microcatheter run through calloso-marginal artery lling antero-superior part of the nidus draining into two corical veins (in arrows); (c) Run through pericallosal artery lls the anterior inferior part of the nidus draining into large vein; (d) Dual microcatheter run shows lling of both the compartments
a
b
c
d
13 Interventions inIntracranial andSpinal Arteriovenous Malformations
139
a
d
b
e
c
f
Fig. 13.12 (a) Right ICA angiogram shows callosal AVM supplied by pericallosal artery; (b, c, & d) Marathon was navigated into distal peri­callosal artery and two draining veins: inferior sagittal sinus and inter­nal cerebral veins. 25% glue was injected; (e) Immediate control angio
Technical Aspects ofGlue Embolization
The techniques of glue embolization were introduced in 1980s and perfected over the years by eminent practitioners like P. Lasjaunias, K. Terbrugge, A. Berenstein, and A.Valavanis [1, 15, 16]. Initially, the role of glue was limited to targeted and adjunct embolization. Later as experience gained substantial proportion of AVMs, particularly SM<3 grade lesions could be cured by glue embolization alone. For example, in the Zurich series of Valavanis comprising 644 patients of brain AVMs, 40% were cured by complete embo­lization with overall morbidity and mortality of 1.5% and
0.8%, respectively [1]. Glue is still considered a valuable embolic agent in the treatment of AVMs by many physicians across the world (Fig.13.12). The following discussion high­lights the essential strategies/technical aspects of glue embolization.
• Strict intranidal deposition of the embolic material is the goal in the embolization of an AVM.Though applies for any liquid embolic agent, this should be religiously fol­lowed when using glue, as excessive or premature venous penetration can result in rupture of the unobliterated stu-
shows complete embolization with a few residual angiogenetic changes; (f) Check DSA 1 month later shows no evidence of any vascular malformation
lae. Obliterating a long segment of the feeding artery, on the other hand, can lead to ischemic damage of normal brain parenchyma.
• To achieve this goal, repeated super selective microcath­eterizations of various feeder pedicles are needed. A larger or multicompartmental nidus with multiple feeders will require several sequential microcatheterizations to be completely obliterated. This can be achieved in the same or multiple sittings.
• An alternative technique in multicompartmental AVMs is the simultaneous multi-microcatheterization technique, which means navigation of two or microcatheters via as many feeder pedicles at the same time. This may require bilateral femoral or even an additional radial access.
• Flow-guided microcatheters of size 1.2F or 1.5F are gen­erally used for superselective navigation. While using microguidewires (0.07″/0.08″) for navigating microcath­eters through small caliber feeding arteries, care should be taken not to perforate them or the nidi.
• The microcatheter tip is positioned as distally as possible in the feeding artery, that is, beyond all the normal branches supplying the adjacent brain parenchyma and